Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Stockholders' Equity (Unaudited)

v3.22.4
Condensed Consolidated Interim Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income
Preferred stock
Accumulated deficit
Beginning Balance at Jun. 30, 2021 $ 10,581 $ 1 $ 106,853 $ 21 $ 14,931 $ (111,225)
Beginning Balance, shares at Jun. 30, 2021   655,000        
Issuance of shares and warrants - net of issue costs 13,634   13,634      
Issuance of shares and warrants - net of issue costs, shares   144,000        
Conversion of Series C Preferred stock to common stock     1,256   (1,256)  
Conversion of Series C preferred stock to common stock, shares   29,000        
Exercise of 2020 Investor Warrants for cash 69   69      
Exercise of 2020 Investor Warrants for Cash, shares   1,000        
Exercise of pre-funded warrants for cash 5   5      
Exercise of pre-funded warrants for cash, shares   96,000        
Warrants issued for services 31   31      
Stock option expense 811   811      
Series A Preferred cash dividend (2)         (2)
Series C Preferred stock dividend     2,462     (2,462)
Series C Preferred stock dividend, shares   34,000        
Loss for the period (5,966)         (5,966)
Ending Balance at Sep. 30, 2021 19,163 $ 1 125,121 21 13,675 (119,655)
Ending Balance, shares at Sep. 30, 2021   959,000        
Beginning Balance at Jun. 30, 2021 10,581 $ 1 106,853 21 14,931 (111,225)
Beginning Balance, shares at Jun. 30, 2021   655,000        
Loss for the period (11,859)          
Ending Balance at Dec. 31, 2021 14,102 $ 1 126,829 21 12,801 (125,550)
Ending Balance, shares at Dec. 31, 2021   980,000        
Beginning Balance at Sep. 30, 2021 19,163 $ 1 125,121 21 13,675 (119,655)
Beginning Balance, shares at Sep. 30, 2021   959,000        
Conversion of Series C Preferred stock to common stock     874   (874)  
Conversion of Series C preferred stock to common stock, shares   21,000        
Warrants issued for services 4   4      
Stock option expense 830   830      
Series A Preferred cash dividend (2)         (2)
Loss for the period (5,893)         (5,893)
Ending Balance at Dec. 31, 2021 14,102 $ 1 126,829 21 12,801 (125,550)
Ending Balance, shares at Dec. 31, 2021   980,000        
Beginning Balance at Jun. 30, 2022 11,795 $ 1 135,575 21 12,554 (136,356)
Beginning Balance, shares at Jun. 30, 2022   1,311,000        
Issuance of shares and warrants - net of issue costs 1,903 $ 1 1,902      
Issuance of shares and warrants - net of issue costs, shares   262,000        
Stock option expense 518   518      
Series A Preferred cash dividend (2)         (2)
Series C Preferred stock dividend     362     (362)
Series C Preferred stock dividend, shares   43,000        
Loss for the period (4,596)         (4,596)
Ending Balance at Sep. 30, 2022 9,618 $ 2 138,357 21 12,554 (141,316)
Ending Balance, shares at Sep. 30, 2022   1,616,000        
Beginning Balance at Jun. 30, 2022 11,795 $ 1 135,575 21 12,554 (136,356)
Beginning Balance, shares at Jun. 30, 2022   1,311,000        
Loss for the period (8,050)          
Ending Balance at Dec. 31, 2022 6,598 $ 2 140,571 21 10,776 (144,772)
Ending Balance, shares at Dec. 31, 2022   1,673,000        
Beginning Balance at Sep. 30, 2022 9,618 $ 2 138,357 21 12,554 (141,316)
Beginning Balance, shares at Sep. 30, 2022   1,616,000        
Conversion of Series C Preferred stock to common stock     1,778   (1,778)  
Conversion of Series C preferred stock to common stock, shares   42,000        
Additional shares issued on reverse stock split, shares   15,000        
Stock option expense 436   436      
Series A Preferred cash dividend (2)         (2)
Loss for the period (3,454)         (3,454)
Ending Balance at Dec. 31, 2022 $ 6,598 $ 2 $ 140,571 $ 21 $ 10,776 $ (144,772)
Ending Balance, shares at Dec. 31, 2022   1,673,000